长非编码RNAs:有争议的角色在药物耐药性的固体瘤通过自介导自
Mohamed J Saadh1,2, Muhammad Ali Abdulllah Almoyad3, Meryelem Tania Churampi Arellano4
1Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
Cancer chemotherapy and pharmacology
|September 28, 2023
概括
长非编码RNAs (lncRNAs) 调节自,这是影响癌症药物耐药性的细胞过程. 本综述探讨了lncRNA-自轴如何影响固体瘤的治疗结果.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 是细胞过程中的关键调节者.
- 自是一种细胞循环机制,在癌症中起着双重作用,并与瘤发生有关.
- 治疗诱导的自可以促进对抗癌药物的耐药性.
研究的目的:
- 审查目前对癌症药物耐药性中的lncRNA-自轴的理解.
- 探索 lncRNAs 在调节自依赖药物耐药性的有争议的作用.
- 总结了在固体瘤中自的 lncRNA 调节的基础机制.
主要方法:
- 关于 lncRNAs,自和癌症药物耐药性的最近研究的文献综述.
- 对各种固体瘤中 lncRNA-自相互作用的研究进行分析.
- 检查拟议的分子机制,包括微RNA介导调节.
主要成果:
- lncRNAs显著调节自,影响癌细胞对治疗的反应.
- lncRNAs在耐药性中的作用取决于上下文,它们可以作为促进剂或抑制剂.
- 自的lncRNA介导调节通常涉及微RNA相互作用.
结论:
- lncRNA-自轴是癌症抗药性的一个关键因素.
- 向lncRNA-自途径为克服耐药性的潜在治疗策略提供了潜在的治疗策略.
- 需要进一步的研究来阐明复杂的相互作用和治疗影响.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


